Stay updated on Cabozantinib-Pemetrexed in Lung, Urothelial, Mesothelioma Clinical Trial
Sign up to get notified when there's something new on the Cabozantinib-Pemetrexed in Lung, Urothelial, Mesothelioma Clinical Trial page.

Latest updates to the Cabozantinib-Pemetrexed in Lung, Urothelial, Mesothelioma Clinical Trial page
- Check2 days agoNo Change Detected
- Check9 days agoChange DetectedAdded a government operating status notice and a v3.2.0 revision; removed the previous v3.1.0 revision. The page now communicates potential service delays and open NIH Clinical Center status, plus the updated software version.SummaryDifference6%
- Check16 days agoChange Detected- Updated terminology: "Malignant mesothelioma" changed to "Mesothelioma, malignant". - Revision/version updated from v3.0.2 to v3.1.0.SummaryDifference0.4%
- Check23 days agoNo Change Detected
- Check30 days agoChange DetectedRevision bumped from v3.0.1 to v3.0.2, and the 'Back to Top' link was removed.SummaryDifference0.4%
- Check37 days agoChange DetectedThe web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content. Additionally, a 'Back to Top' feature has been added for improved navigation.SummaryDifference0.4%
- Check44 days agoChange DetectedThe web page has added significant medical terms and a facility name while removing various location-related terms and specific cancer-related topics, indicating a shift in focus towards more specialized content.SummaryDifference9%
- Check59 days agoChange DetectedThe web page has been updated from version 2.16.11 to version 2.16.12.SummaryDifference0.8%
Stay in the know with updates to Cabozantinib-Pemetrexed in Lung, Urothelial, Mesothelioma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Cabozantinib-Pemetrexed in Lung, Urothelial, Mesothelioma Clinical Trial page.